Skip to main content
Log in

Multiple Sklerose: Grundlagen und Hypothesen der modernen Ursachenforschung

Multiple sclerosis principles and hypotheses of research on its cause

  • Surveys Of Progress
  • Published:
Zeitschrift für Neurologie Aims and scope Submit manuscript

Summary

The majority of investigators considers an exogenous, probably infectious agent as the cause of multiple sclerosis (MS). There is also widespread agreement, however, that it must be an agent with unusual properties, and that a particular immunological reaction is prerequisite for the manifestation of the disease. The key words of this concept are “slow virus infection” and “auto-immunity”.

The development leading to the socalled neuroallergic theory and its basic aspects are summarized.

The chemical analysis of myelin composition under normal and pathological conditions has yielded divergent results, partly due to the lack of adequate correlation of biochemical data and histopathology. Further confirmation of findings, that areas of white matter not affected by the demyelinating process have altered myelin composition, would be pathologically significant as a indication, that an (acquired ?) pathochemical situation precedes the morphological features of MS.

The delayed sensitivity reaction found in EAE, with an antigen-antibody response in regional lymph nodes, evolved the concept, that a cell-bound reaction is also important in MS. The role of sensitized lymphocytes as mediators of this reaction was recognized only later, however. For some time research was focussed on the chemical composition of brain/spinal cord tissue and adjuvants, and the attempt to establish the chemical nature of the decisive pathogenic substance in EAE. The work on the encephalitogenic protein evolving from this approach is briefly reviewed. In relation to this, the necessity of more detailed studies on the nature of white matter, especially the myelin proteins in normal and pathological tissue of human origin, is pointed out.

The passive transfer of EAE by lymphocytes, electron microscopic studies on the morphology involved, differences in resistance of various animal species established the importance of cellular reactions in EAE. On the other hand, the role of humoral antibodies, found in similar patterns in EAE and in MS, as well as the possibility of protective antibodies, require closer study. The two main lines of investigation in this area are the cytotoxic factor in serum and cerebrospinal fluid and the elevated content of immunoglobulins, especially of the IgG group, in cerebrospinal fluid and brain/spinal cord tissue. In this connection the role of complement has also been studied. In the discussion of the results and the significance of investigations on these problems, the work on immunoglobulins is given more detailed consideration. Reference is made to the methodic possibilities of morphological and chemical studies of the immunoglobulins in brain and spinal cord tissue.

The progress in virological techniques and the advent of systematic epidemiological investigations reactivated the search for an exogenic, possibly infectious agent as the cause of MS. An important step in this direction was also the finding, that myelin lamellae are spirally arranged membranes derived from oligodendrocytes in the white matter of central nervous system, and thus components of cells which may be the site of virus infection.

In addition to the relation of MS-prevalence to climate, bourne out by earlier studies, epidemiological research on MS received an important new impetus from investigations on population groups transferred from areas of high MS-frequency to regions in which MS was a rare disease. Studies in South Africa and especially in Israel have shown, that differences are significant only in the immigrant generation, and that MS occurs less frequently in groups with a low standard of hygiene. These observations point to an exogenic factor. The majority of the newer epidemiological studies appear to converge on the concept of a childhood infection followed by a clinical latency period before manifestation of the demyelinating disease. Here the slow virus concept is introduced as a central hypothesis for the etiology and pathogenesis of MS, and the necessity of particular virological studies becomes evident. Kuru, the Icelandic slow virus infections and especially scrapie are receiving intensive study. The epidemiological and virological investigations bearing on these problems are reviewed. Another concept based on slow virus action and clinically light or inapperent childhood infection as the essential prerequisite for MS later in life deals with myxoviruses, especially measles. This work is alo summarized. Strong encouragement was given to the myxovirus hypothesis by the discovery, that subacute slerosing panencephalitis (SSPE) is a slow virus infection caused by the measles virus. A lot of work has been done and is under way on measles and MS; in none of the cases of MS have titre elevations been found even distantly approaching those seen in SSPE, however, and the transfer of MS to primates or other animals has thus far been unsuccessful. The question is thus still open, whether the weak elevations of myxovirus titres found in MS are pathogenetically related phenomena or non-related booster effects.

The study of these virological problems calls for a third type of epidemiological investigation: the intensive systematic and prospective survey of small areas with high MS- incidence and -prevalence. Results of investigations of this kind, which thus far have been based chiefly on retrospective data, are cited.

A number of publications exist on ultrastructural morphology. For valid conclusions bioptic studies are necessary. Obviously, the difficult decision to perform biopsy in the human limits the availability of such material. In MS, stereotactic operation in cases with severe ataxia represents a legitimate indication for biopsy. Reference is made to the development of microbioptic procedures for this purpose.

The orientation of research towards an exogenic cause of MS has not invalidated the autoimmune hypothesis for this disease. The probability, that a special immunological situation, perhaps in connection with the action of unspecific stress factors, is prerequisite for the clinical manifestation of MS. makes immunology an important line of future research.

A discussion of present therapeutic approaches, based predominantly on the idea of immunosuppressive action, is included in this survey, with particular reference to initial results with antilymphocytic globulin.

Therapy of diseases such as MS, in which etiology and pathogenesis are still unclear, generally — and often prematurely — reflects the dominant trends of basic and clinical research. Present therapy obviously is a child of the neuroallergic or autoimmunological era of MS-research. A more effective treatment of MS will hardly be possible before empiric schemes and procedures relying on hypotheses are replaced by methods based on well-founded knowledge concerning the cause of the disease. To achieve this end, not only greater facilities for research on MS, but also a more detailed exchange of information and comparable methods of documentation are important. In conclusion, the important contributions, which lay organizations have made to activate and promote research on the cause of MS, are acknowledged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  • Acheson, E. D.: The epidemiology of multiple sclerosis. In McAlpine, D., Lumsden, Ch. E., Acheson, E. D.: Multiple Sclerosis — a Reappraisal 3–58. Livingstone 1965.

  • Adams, J. M., Brown, W. J.: Studies on inclusion bodies in early and late demyelinating disease. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad. Int. Arch. Allergy 36, 83–101 (1969).

    Google Scholar 

  • — Imagawa, D. T.: Measles antibodies in multiple sclerosis. Proc. Soc. exp. Biol. (N.Y.) III, 3, 562 (1962).

    Google Scholar 

  • Allison, R. S., Millar, J. H. D.: Prevalence of disseminated sclerosis in northern Ireland. Ulster med. J. Suppl. 2, 235 (1954); zit. n. McAlpine, Lumsden, Acheson.

    Google Scholar 

  • Alter, M., Leibowitz, U., Halpern, L.: Clinical studies on multiple sclerosis in Israel. II. A comparison between European and Afro-Asian patients. J. Neurol. Neurosurg. Psychiat. 27, 522–529 (1964).

    Google Scholar 

  • Alvord, E. C., Sarka, H., Cheng-Mei, S., Kies, M. W.: Multiplicity of encephalitogenic myelin basic proteins. II. Antigenic determinants related to species of origin and molecular size. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 203–217 (1969).

    Google Scholar 

  • Bammer, H. G.: Felduntersuchungen über multiple Sklerose in Unterfranken. Stuttgart: Thieme 1960.

    Google Scholar 

  • — Schaltenbrand, G., Solcher, H.: Zwillingsuntersuchungen bei multipler Sklerose. Dtsch. Z. Nervenheilk. 181, 261 (1960).

    Google Scholar 

  • Bammer, H.: Liquorkomplement und multiple Sklerose. Dtsch. Z. Nervenheilk. 188, 271–288 (1966).

    Google Scholar 

  • Bauer, H. J.: Methoden der immunosuppressiven Therapie der MS-Corticosteroide. Sympos. über Immunosuppressive Therapie der MS, Göttingen 1969.

  • — History, Facts, Problems and Clinical Aspects of Multiple Sclerosis. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad. Int. Arch. Allergy 36, 3–21 (1969).

    Google Scholar 

  • — Firnhaber, W., Reisert, P. M., Schipper, H., Volles, E.: Klinische und endokrinologische Studien über die Behandlung der multiplen Sklerose mit synthetischen ACTH-Präparaten. Wien. Z. Nervenheilk. Suppl. 2, 204–217 (1969).

    Google Scholar 

  • — Gottesleben, A.: Quantitative immunochemical studies of cerebrospinal fluid proteins in relation to clinical activity of multiple sclerosis. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 643–648 (1969).

    Google Scholar 

  • -- -- Warecka, K.: Quantitative Immunochemie der Liquorproteine. In: Zukunft der Neurologie (Ed.: H. G. Bammer). S. 200–213, 1967.

  • Beck, I., Daniel, P. M.: Kuru and scrapie compared: are they examples of system degeneration? NINDB Monograph No. 2, Slow, Latent and Temperate Virus Infections, p. 85–93, 1965.

  • Bornstein, M. B.: Anti-neuroglial and anti-neuronal cell factors in experimental allergic encephalomyelitis and multiple sclerosis. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 574–584 (1969).

    Google Scholar 

  • — Appel, S. H.: Tissue culture studies of demyelination. Ann. N.Y. Acad. Sci. 122, 280–286 (1965).

    Google Scholar 

  • — Crain, S. M.: Functional studies of cultured brain tissues as related to “demyelinative disorders”. Science 148, 1242–1244 (1965).

    Google Scholar 

  • Brody, I. A.: Chronic sequelae of tick-borne encephalitis and Vilyuisk Encephalitis. NINDB Monograph No. 2, Slow, Latent and Temperate Virus Infections, p. 111–113, 1965.

  • Calhoun, C. L., Skin Joong Oh: Bericht in Medical Tribune vom 3. 10. 69 über einen Vortrag auf dem 74. Kongreß der National Medical Association.

  • Caspary, E. A., Simpson, C. A.: Dimercaprol in multiple sclerosis and allergic encephalomyelitis. Lancet 1964 II, 909.

    Google Scholar 

  • — Simpson, R. E., Field, E. J.: Some observations on the role of circulating antibody in protection against experimental allergic encephalomyelitis. Z. Immun.-Forsch. 130, 454–459 (1966).

    Google Scholar 

  • Clausen, J.: Proteins in normal cerebrospinal fluid not found in serum. Proc. Soc. exp. Biol. (N.Y.) 107, 170–172 (1961).

    Google Scholar 

  • — Hansen, I. B.: Myelin constituents of human central nervous system. Acta neurol. scand. 46, 1–17 (1970).

    Google Scholar 

  • Cohen, S., Bannister, R.: Immunoglobulin synthesis within the central nervous system in disseminated sclerosis. Lancet 1967, I, 366.

    Google Scholar 

  • Crain, S. M.: Development of „organotypic“ bioelectric activities in central nervous tissue during maturation in culture. Int. Rev. Neurobiol. 9, 1–43 (1966).

    Google Scholar 

  • Cumings, J. N.: Cerebral lipid biochemistry in the demyelinations. Biochemical Aspects of Neurological Disorders. Second Series, p 229–251 1965.

  • -- Lipid profiles in purified myelin from control and multiple sclerosis brain tissue. Bericht über 2. Sitzung des Internat. Soc. Neurochem, Mailand, S. 51, Sept. 1969.

  • Cumings, J. N.: Goodwin, H.: Sphingolipids and phospholipids of myelin in multiple sclerosis. Lancet 1968 II, 664.

    Google Scholar 

  • Dassel, H.: Bericht, Symposium über immunosuppressive Therapie der MS. Göttingen 1969.

  • Dean, G.: Annual incidence, prevalence and mortality of multiple sclerosis in white South Africanborn and in white immigrants to South Africa. Brit. med. J. 1967 II, 724–729.

    Google Scholar 

  • Dencker, S. J.: Studies on specific cerebrospinal gammaglobulin components. Acta neurol. scand. 39, Suppl. 4, 317–322 (1963).

    Google Scholar 

  • Dick, G. W. A., Mc.Allister, J. J., Mc.Keown, Campbell, A. M. G.: Multiple sclerosis and scrapie. J. Neurol. Neurosurg. Psychiat. 28, 560–562 (1965).

    Google Scholar 

  • Drescher, J.: Demonstration of measles virus antibody in multiple sclerosis by means of the photometric ACU Method. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 117–120 (1969).

    Google Scholar 

  • Ferraro, A.: Studies on multiple sclerosis. I. Multiple sclerosis viewed as a chronic disseminated encephalomyelitis. II Etio-pathogenesis of multiple sclerosis (infectious allergic or toxic allergic). J. Neuropath. exp. Neurol. 17, 278–297 (1958).

    Google Scholar 

  • Field, E. J.: Multiple Sclerosis and slow virus infections of the central nervous system. Wien. Z. Nervenheilk. Suppl. 2, 95–100 (1969).

    Google Scholar 

  • — Raine, C. S.: Experimental allergic encephalomyelitis. An electron microscopic study. Amer. J. Path. 49, 537–553 (1966).

    Google Scholar 

  • Firnhaber, W.: Vorkommen der multiplen Sklerose und epidemiologische Aspekte in einem umschriebenen Gebiet Südniedersachsens. — Organisation eines Areals für prospektive Langzeitbeobachtungen. Habilit.-Schrift, Göttingen, 1969.

    Google Scholar 

  • Folch, J., Lees, M., Sloane-Stanley, G. H.: Isolation and purification of total lipids from animal tissues. J. biol. Chem. 226, 497 (1957).

    Google Scholar 

  • Freund, J., Lipton, M. M., Morrison, L. R.: Demyelination in the Guinea pig in chronic encephalomyelitis produced by injecting Guinea pig brain in oil emulsion containing a variant of mycobacterium butyricum. Arch. Path. 50, 108–121 (1950).

    Google Scholar 

  • Frick, E.: Immunhistologische Untersuchungen über die intrathekale Gamma-Globulinbildung bei der allergischen Encephalomyelitis. Z. ges. exp. Med. 138, 408–414 (1964).

    Google Scholar 

  • -- Die Bedeutung des Antilymphocytenglobulins für die Therapie der multiplen Sklerose. Sympos. über Immunosuppressive Therapie der MS. Göttingen 1969.

  • — Zur Pathogenese entzündlicher Nervenerkrankungen. Fortschr. Med. 87, 1191–1194 (1969).

    Google Scholar 

  • — Stickl, H.: Immunologische Untersuchungen zur Pathogenese der multiplen Sklerose. Wien. Z. Nervenheilk. Suppl. 2, 145–149 (1969).

    Google Scholar 

  • Gajdusek, D. C.: Kuru in New Guinea and the origin of the NINDB study of slow, latent and temperate virus infections of the nervous system of man. NINDB Monograph No. 2, Slow, Latent and Temperate Virus Infections, p. 3–12, 1965.

  • — Discussion on Kuru, Scrapie and the experimental Kuru-like syndromes in Chimpanzees. Current Topics in Microbiol. 40, 59–63 (1967).

    Google Scholar 

  • — Gibbs, C. J., Jr., Alpers, M.: Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (Lond.) 209, 794–796 (1966).

    Google Scholar 

  • Georgi, F., Hall, P., Müller, H. R.: Zur Problematik der multiplen Sklerose. Basel: Karger 1961.

    Google Scholar 

  • Geren, B. B.: The formation from the Schwann cell surface of myelin in the peripheral nerves of chick embryos. Exp. Cell. Res. 7, 558–562 (1954).

    Google Scholar 

  • Gerstel, B., Tavaststjerna, M. G., Hayman, R. B., Eng, L. F., Smith, J. K.: Alterations in myelin fatty acids and plasmalogens in multiple sclerosis. Ann. N.Y. Acad. Sci. 122, 405–416 (1965).

    Google Scholar 

  • Gerstel, B., Eng, L. F., Tavaststjerna, M., Smith, J. K.: Lipid and protein studies on multiple sclerosis white matter. Bericht über 2. Sitzg. Internat. Soz. Neurochem., S. 185, Mailand, Sept. 1969.

  • Gibbs, C. J., Gajdusek, D. C.: The epidemiology of slow virus infections. Transact. 32. North. Amer. Wildlife and Natural Resources Conference, March 1967.

  • Gibbs, C. J., Jr., Gajdusek, D. C., Morris, I. A.: Viral characteristics of the scrapie agent in mice. NINDB Monograph No. 2, Slow, Latent and Temperate Virus Infections, p. 195–202, 1965.

  • — Asher, D. M., Alpers, M., Beck, E., Daniel, P. M., Mathews, W. B.: Creutzfeldt-Jacob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science 161, 388–389 (1968).

    Google Scholar 

  • Gudmundsson, K. R., Gudmundsson, G.: Studies in multiple sclerosis V. Multiple sclerosis in Iceland. Acta psychiat. scand. 38, Suppl. 2 (1962).

    Google Scholar 

  • Hochwald, G. M., Thorbecke, G. J.: Trace proteins in cerebrospinal fluid and other biological fluids. Clin. chim. Acta 8, 678–684 (1963).

    Google Scholar 

  • Hyllested, K.: Lethality, duration and mortality of disseminated sclerosis in Denmark. Acta psychiat. scand. 36, 553–564 (1961).

    Google Scholar 

  • Isacson, P.: The role of host incorporated antigens in the immune response to measles virus Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 139–145 (1969).

    Google Scholar 

  • Kabat, E. A.: Immunochemical mechanisms in experimental acute disseminated encephalomyelitis and their relation to multiple sclerosis. 6. Internat. Neurol. Congress, Bruxelles, Juli 1957, Rapports et discussions, p. 31–47.

  • — Wolf, A., Bezer, A. E.: The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. Exper. Med. 85, 117–130 (1947).

    Google Scholar 

  • Katz, M., Rorke, L. B., Masland, W. S., Koprowski, H., Tucher, S. H.: Transmission of an encephalitogenic agent from brains of patients with subacute sclerosing panencephalitis to ferrets. New Engl. J. Med. 279, 793–798 (1968).

    Google Scholar 

  • Kies, M. W., Alvord, E. C.: Allergic Encephalomyelitis. Springfield (Ill.): Thomas 1959.

    Google Scholar 

  • — Multiplicity of encephalitogenic myelin basic proteins I. Relative molecular sizes related to methods of preparation. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 182–202 (1969).

    Google Scholar 

  • Klatzo, I., Gajdusek, D. C., Zigas, V.: Pathology of Kuru. Lab. Invest. 8, 799–847 (1959).

    Google Scholar 

  • Klein, F., Parnitzke, K. H.: Geomedizinische Untersuchungen über die Verbreitung der multiplen Sklerose im Siedlungsraum um Magdeburg. Dtsch. Gesundh.-Wes. 18, 1677–1682 (1963).

    Google Scholar 

  • Kosanen, T. U., Waksman, B. H., Samuelsson, J. K.: Radioautographic study of cellular mechanisms in delayed hypersensitivity. II Experimental allergic encephalomyelitis in the rat. J. Neuropath. exp. Neurol. 22, 367–380 (1963).

    Google Scholar 

  • Kurland, L. T.: The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Amer. J. Hyg. 55, 457–476 (1952).

    Google Scholar 

  • — Westlund, K. B.: Epidemiological factors in the etiology and prognosis of multiple sclerosis. Ann. N.Y. Acad. Sci. 58, 682–701 (1954).

    Google Scholar 

  • Kurtzke, J. F.: Multiple sclerosis in South Africa. Brit. med. J. 1967, 739.

  • — An evaluation of the geographic distribution of multiple sclerosis. Acta neurol. scand. 42, Suppl. 19, 91–117 (1966).

    Google Scholar 

  • — On the fine structure of the distribution of multiple sclerosis. Acta neurol. scand. 43, 257–282 (1967).

    Google Scholar 

  • Kurtzke, J. F., Some epidemiological features compatible with an infectious origin for multiple sclerosis. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 59–81 (1969).

    Google Scholar 

  • Kuwert, E.: Komplement (C′)-System und multiple Sklerose. Vortrag, Symposium über immunosuppressive Therapie der multiplen Sklerose. Göttingen 1969.

  • — Noll, K., Firnhaber, W.: Komplementsystem und Liquor cerebrospinalis. III. Das Verhalten von Gesamt-C′ und C′1–C′4 in Serum und Liquor von Patienten mit multipler Sklerose. Z. Immun.-Forsch. 135, 462–480 (1968).

    Google Scholar 

  • Lamoureux, G., Boulay, G., Borduas, A. G.: A cytotoxic antibody for cultured nervous tissue in serum and cerebrospinal fluid from rhesus monkeys with allergic encephalomyelitis. Clin. exp. Immunol. 1, 307 (1966).

    Google Scholar 

  • Lampert, P.: Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis. Acta neuropath. (Berl.) 9, 99–126 (1967).

    Google Scholar 

  • Leibowitz, U., Halpern, L., Alter, M.: Clinical studies of multiple sclerosis in Israel. I: A clinical analysis based on a country-wide survey. Arch. Neurol. (Chic.) 10, 502–512 (1964).

    Google Scholar 

  • -- Kahana, E., Alter, M.: A national registry of multiple sclerosis in Israel. Bericht Sympos. üb. Immunosuppressive Therapie der Multiplen Sklerose. Göttingen, 1969.

  • — Sharon, D., Alter, M.: Geographical considerations in multiple sclerosis. Brain 90, 871–886 (1967).

    Google Scholar 

  • Levine, S.: Allergic encephalomyelitis: cellular transformation and vascular blockade. J. Neuropath. exp. Neurol. 24, 6–20 (1970).

    Google Scholar 

  • Lhermitte, F., Marteau, R., Gazengel, J.: Traitement de la sclerose en plaques par L′ I.G.A.L. (etude provisoire). Symposium über Immunosuppressive Therapie der M.S. Göttingen, 1969.

  • -- -- -- Traitement de la sclerose en plagues par de la prednisone a fortes doses poursnivie a doses degressives de la facon prolongee. Sympos. über Immunosuppressive Therapie der M.S. Göttingen, 1969.

  • -- -- -- Loridan, M.: Etude clinique comparee de l'efficacité de la prednison, de l'Azathioprine et de l'association prednisone-azathioprine sur la sclerose en plaques. Symposium über Immunosuppressive Therapie der M.S. Göttingen, 1969.

  • Lück, H.: Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterization with special reference to multiple sclerosis. Acta neurol. scand. 43, Suppl. 28, 1–136 (1967).

    Google Scholar 

  • Lumsden, C. E.: Properties and Significance of the Demyelinating Antibody in Multiple Sclerosis. In: Pathogenesis and Etiology of Demyelinating Dis. Add. ad Int. Arch. Allergy 36, 247–273 (1969).

    Google Scholar 

  • — Robertson, D. M.: Chemical studies on experimental allergic encephalomyelitis. Peptide as the common denominator in all encephalitogenic “antigens”. J. Neurochem. 13, 127–162 (1966).

    Google Scholar 

  • — New and unexpected findings on the chemical nature of the ECM-promoting factor (S) in bovine spinal cord. Demyelinisierende Encephalomyelitis (Ed. E. Pette u. H. Bauer), S. 168–182. Stuttgart: Fischer 1964.

    Google Scholar 

  • Mackay, R. P., Myrianthopoulos, N. C.: Multiple Sclerosis in twins and their relatives. Arch. Neurol. (Chic.) 15, 449–462 (1966).

    Google Scholar 

  • MacPherson, F. C., I. B. R. Cosgrove: An unusual IgG globulin. Frequency of occurence in cerebrospinal fluid in multiple sclerosis. Arch. Neurol. (Chic.) 19, 503–509 (1968).

    Google Scholar 

  • Mai, K.: Measles antibodies in multiple sclerosis patients and controls (biostatistical evaluation). Pathologenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 109–113 (1969).

    Google Scholar 

  • Margulis, M., Soloviev, V. D., Shubladse, R. K.: Etiology and pathogenesis of acute sporadic disseminated encephalomyelitis and multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 9, 63–74 (1946).

    Google Scholar 

  • McAlpine, D., Lumsden, Ch. E., Acheson, E. D.: Multiple Sclerosis — a Reappraisal. Livingstone 1965.

  • McCall, M. G., Sutherland, I. M., Acheson, E. D.: The frequency of multiple sclerosis in Western Australia. Acta neurol. scand. 45, 151–165 (1969).

    Google Scholar 

  • ter Meulen, V., Müller, D., Enders-Ruckle, G., Neuhoff, V., Käckell, M. Y., Joppich, G.: Ist die subakute progressive Panencephalitis eine Masernerkrankung? Ein Beitrag zur Klinik, Morphologie und Ätiologie. Dtsch. med. Wschr. 93, 1303–1308 (1968).

    Google Scholar 

  • Morgan, I. M.: Allergic encephalomyelitis in monkeys in response to injection of normal monkey cord. J. Bact. 51, 614–615 (1946).

    Google Scholar 

  • Moscarello, M. A., Lowden, J. A.: Differences in fatty acid composition of myelin subfractions in multiple sclerosis. Bericht über 2 Sitzg. Internat. Soc. Neurochem. Mailand, Sept. 1969, S. 297.

  • Palsson, P. A., Pattison, I. H., Field, E. J.: Transmission experiments with multiple sclerosis. NINDB Monograph No. 2, 49–54 (1965).

  • Panelius, M.: The prevalence of multiple sclerosis and some related neuropathological syndromes in South-West Finland. Acta neurol. scand. 41, Suppl. 13, 653–659 (1965).

    Google Scholar 

  • Panelius, U. K., Kivalo, E., Hokkanen, E., Meurman, T.: Multiple sclerosis in Finland. Further studies on its distribution and prevalence. Acta neurol. scand. 44, 631–642 (1968).

    Google Scholar 

  • Paterson, P. Y.: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. exp. Med. 111, 119–136 (1960).

    Google Scholar 

  • — Jacobs, A. F., Coia, E. M.: Complement fixing antibrain antibodies and allergic encephalomyelitis. II Further studies concerning thin protective role in: Autoimmunity-experimental and clinical aspects I. Ann. N.Y. Acad. Sci. 124, 292–298 (1965).

    Google Scholar 

  • Pattison, I. H.: Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. NINDB Monograph No. 2, 249–257 (1965).

  • Perier, O., Gregoire, A.: Electron microscopic features of multiple sclerosis lesions. Brain 88, 937–952 (1965).

    Google Scholar 

  • Pette, E., Kuwert, E.: Evaluation of multiple sclerosis sera against measles antigen in the complement-fixation test. Arch. ges. Virusforsch. 16, 141–147 (1965).

    Google Scholar 

  • — Palacios, O.: The possible role of measles virus in the pathogenesis of multiple sclerosis. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 102–108 (1969).

    Google Scholar 

  • Pette, H.: Die akut entzündlichen Erkrankungen des Nervensystems. Leipzig: Thieme 1942.

    Google Scholar 

  • Poskanzer, D. C.: Epidemiological evidence for a viral etiology of multiple sclerosis. NINDB Monograph No. 2, Slow, Latent and Temperate Virus Infections, p. 55–63 (1965).

  • — Schapira, K., Miller, H.: Epidemiology of multiple sclerosis in the counties of Northumberland and Durham. J. Neurol. Neurosurg. Psychiat. 26, 368–376 (1963).

    Google Scholar 

  • Renschler, H.: Zur Behandlung der chronischen Formen von Encephalomyelitiden mit ACTH. Sympos. über Immunosuppressive Therapie der M.S., Göttingen, 1969.

  • Ridley, A.: Localization of gamma-globulin in experimental encephalomyelitis by the fluorescent antibody technique. Z. Immun.-Forsch. 125, 173–190 (1963).

    Google Scholar 

  • Rinne, U. K.: Electron microscopy of a multiple sclerosis brain biopsy. Ann. Med. intern. Fenn. 57, 179–183 (1968).

    Google Scholar 

  • Rivers, T. M., Schwendtker, F. F.: Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. exp. Med. 61, 689–702 (1935).

    Google Scholar 

  • Roboz-Einstein, E., Csejtey, I., Davis, W. J., Lajtha, A., Marks, N.: Enzymatic degradation of the encephalitogenic protein. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 363–375 (1969).

    Google Scholar 

  • — Robertson, D. M., Di Caprio, I. M., Moore, W.: The isolation from bovine spinal cord of a homogeneous protein with encephalitogenic activity. J. Neurochem. 9, 353–361 (1962).

    Google Scholar 

  • Roeder, F., Müller, D., Dames, K.: Die stereotaktische Behandlung der Ataxie bei der multiplen Sklerose. Symp. üb. Immunosuppressive Therapie der Multiplen Sklerose, Göttingen, 1969.

  • Ross, C. A. C., Lenman, I. A. R., Rutter, C.: Infective agents and multiple sclerosis. Brit. med. J. 1965 I, 226–229.

    Google Scholar 

  • Sallström, T.: Das Vorkommen und die Verbreitung der multiplen Sklerose in Schweden. Acta med. scand. Suppl. 137 (1942).

  • Sandberg-Wollheim, M., Zettervall, O., Müller, R.: In vitro synthesis of IgG by cells from the cerebrospinal fluid in a patient with multiple sclerosis. Clin. exp. Immunol. 4, 401–405 (1969).

    Google Scholar 

  • Schaltenbrand, G.: Die multiple Sklerose des Menschen. Leipzig: Thieme 1943.

    Google Scholar 

  • Schapira, K., Poskanzer, D. C., Miller, H.: Familial and conjugal multiple sclerosis. Brain 85, 315–332 (1963).

    Google Scholar 

  • — Familial and conjugal multiple sclerosis. Acta neurol. scand. 42, Suppl. 19, 83–84 (1966).

    Google Scholar 

  • Seitelberger, F.: Autoimmunologische Aspekte der Entmarkungsencephalomyelitiden. Nervenarzt 38, 525–535 (1967).

    Google Scholar 

  • Sever, J. L.: Myxoviruses and multiple sclerosis. Pathogenesis and Etiology of Demyelinating Diseases. Add. ad Int. Arch. Allergy 36, 134–138 (1969).

    Google Scholar 

  • — Kurtzke, I. F.: Delayed dermal hypersensitivity to measles and mumps antigen among multiple sclerosis and control patients. Neurology (Minneap.) 19, 113–115 (1969).

    Google Scholar 

  • — Zeman, W.: Conference on measles virus and subacute sclerosing panencephalitis. Neurology (Minneap.) 18, 1–192 (1968).

    Google Scholar 

  • Sibley, W. A., Foley, J. M.: Infection and immunization in multiple sclerosis. Ann. N.Y. Acad. Sci. 122, 457–468 (1965).

    Google Scholar 

  • Sigurdsson, B., Palsson, P. A., Grinsson, H.: Visna: a demyelinating transmissible disease in sheep. J. Neuropath. exp. Neurol. 16, 389–403 (1957).

    Google Scholar 

  • Simpson, I. F., Tourtellotte, W. W., Kokmen, E., Parker, I. A.: Fluorescent protein tracing in multiple sclerosis brain tissue. Neurology (Minneap.) 18, 295 (1968).

    Google Scholar 

  • Sluga, E., Seitelberger, F.: Zur feinstrukturellen Zytologie der multiplen Sklerose. Sympos. über Immunosuppressive Therapie. Göttingen, 1969.

  • Sutherland, J. M.: Observations on the prevalence of multiple sclerosis in northern Scotland. Brain 79, 635 (1956).

    Google Scholar 

  • — Tyrer, T. H., Eadie, M. T., Casey, T. H., Kurland, L. T.: The prevalence of multiple sclerosis in Queensland, Australia: a field survey. Acta neurol. scand. 42, Suppl. 19, 57–67 (1966).

    Google Scholar 

  • Swank, R. L., Backer, J.: Geographic incidence of multiple sclerosis in Norway. Trans. Amer. neurol. Ass. 75, 274–275 (1950).

    Google Scholar 

  • Suzuki, K., Andrews, J. M., Waltz, I. M., Terry, R. T.: Ultrastructural studies of multiple sclerosis. Lab. Invest. 20, 444–454 (1969).

    Google Scholar 

  • Thormar, H.: Physical, chemical and biological properties of Visna virus and its relationship to other animal viruses. NINDB Monograph No. 2. Slow, Latent and Temperate Virus Infections, p. 335–340 (1965).

  • Thums, K.: Vorläufige Mitteilung über Zwillingsuntersuchungen bei Multipler Sklerose. Dtsch. Z. Nervenheilk. 139, 34–41 (1936).

    Google Scholar 

  • Tourtellotte, W. W., Parker, J. A.: Distribution and subfractionation of immunoglobulins in patients with multiple sclerosis. Trans. Amer. neurol. Ass. 90, 107–112 (1965).

    Google Scholar 

  • — Multiple sclerosis: correlation between immunoglobulin-G in cerebrospinal fluid and brain. Science 154, 1044–1045 (1966).

    Google Scholar 

  • — Multiple sclerosis: brain immunoglobulin-G and albumin. Nature (Lond.) 214, 683–686 (1967).

    Google Scholar 

  • Uchimura, I., Shiraki, H.: A contribution to the classification and the pathogenesis of demyelinating encephalomyelitis, with special reference to the central nervous system lesions caused by the preventive inoculation against rabies. J. Neuropath. 16, 139–203 and 203–208 (1957).

    Google Scholar 

  • Waksman, B. H.: Experimental allergic encephalomyelitis and the “auto-allergic” diseases. Int. Arch. Allergy Suppl. 14 (1959).

  • — Porter, H., Lees, M. B., Adams, R. D., Folch, J.: A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit. J. exp. Med. 100, 451–471 (1954).

    Google Scholar 

  • Wolfgram, F., Fewster, M. E., Mead, I. F.: The amino acids and lipids of myelin in multiple sclerosis. Bericht über 2. Sitzung International Society for Neurochemistry, Mailand, Sept. 69, S. 61.

  • Wüthrich, R.: ACTH-Behandlung der multiplen Sklerose. Sympos. über Immunosuppressive Therapie der M.S. Göttingen, 1969.

  • Zettervall, O., Link, H.: Qualitative alterations of cerebrospinal fluid immunoglobulin G in multiple sclerosis. Bericht, 2. Sitzg. Internat. Soc. Neurochem., Mailand 1969, S. 427.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauer, H.J. Multiple Sklerose: Grundlagen und Hypothesen der modernen Ursachenforschung. Z. Neurol. 198, 5–32 (1970). https://doi.org/10.1007/BF00316133

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00316133

Navigation